Use of high‐normal levels of haemoglobin A1C and fasting plasma glucose for diabetes screening and for prediction: a meta‐analysis
暂无分享,去创建一个
Hitoshi Shimano | Satoru Kodama | Shiro Tanaka | Hirohito Sone | C. Horikawa | K. Fujihara | H. Sone | Shiro Tanaka | H. Shimano | S. Kodama | Kazumi Saito | Y. Yachi | Kazumi Saito | Yoko Yachi | K. Iida | Yasuko Sone | R. Hirasawa | Chika Horikawa | Kazuya Fujihara | Reiko Hirasawa | Kaoruko Iida | Sakiko Yoshizawa | Yasuko Sone | S. Yoshizawa
[1] A. Fryer,et al. Predicting dysglycaemia in patients under investigation for acute coronary syndrome. , 2011, QJM : monthly journal of the Association of Physicians.
[2] M. Ashwell,et al. Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐analysis , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[3] S. Keinänen-Kiukaanniemi,et al. Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease , 2010, Diabetes Care.
[4] Elizabeth Selvin,et al. Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.
[5] J. Chan,et al. Combined Use of a Fasting Plasma Glucose Concentration and HbA1c or Fructosamine Predicts the Likelihood of Having Diabetes in High-Risk Subjects , 1998, Diabetes Care.
[6] R. D'Agostino,et al. Effect of Aging on A1C Levels in Individuals Without Diabetes , 2008, Diabetes Care.
[7] K. Ciechanowski,et al. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test , 2002, Acta Diabetologica.
[8] J. Tuomilehto,et al. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[9] Y. Nose,et al. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study , 2004, Diabetologia.
[10] K. Kosaka,et al. HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study , 2011, The Lancet.
[11] B. Cheung,et al. Haemoglobin A1c is superior to fasting glucose in predicting the incidence of diabetes over 8 years among Chinese. , 2011, Diabetes research and clinical practice.
[12] Richard D Riley,et al. Bivariate random-effects meta-analysis and the estimation of between-study correlation , 2007, BMC Medical Research Methodology.
[13] A. Horvath,et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. , 2009, Clinical chemistry.
[14] G. Guyatt,et al. Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients? , 1994 .
[15] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[16] H. Brenner,et al. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening , 2011, European Journal of Epidemiology.
[17] S. Dharmage,et al. HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review , 2007 .
[18] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[19] C M Rutter,et al. A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations , 2001, Statistics in medicine.
[20] Shyang-Rong Shih,et al. The performance of risk scores and hemoglobin A1c to find undiagnosed diabetes with isolated postload hyperglycemia. , 2011, Endocrine journal.
[21] Roger M Harbord,et al. A unification of models for meta-analysis of diagnostic accuracy studies. , 2007, Biostatistics.
[22] Yao-min Hu,et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance , 2010, Acta Diabetologica.
[23] Naoko Tajima,et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. , 2007, Diabetes research and clinical practice.
[24] Jonathan J Deeks,et al. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. , 2005, Journal of clinical epidemiology.
[25] A. Salmasi,et al. The Glucose Tolerance Test, But Not HbA 1c, Remains the Gold Standard in Identifying Unrecognized Diabetes Mellitus and Impaired Glucose Tolerance in Hypertensive Subjects , 2005, Angiology.
[26] S. Yusuf,et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. , 2003, Diabetes care.
[27] L. Kuller,et al. Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study. , 2001, Journal of clinical epidemiology.
[28] L. Weinehall,et al. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed , 2006, Journal of internal medicine.
[29] S. Tavintharan,et al. A rational alternative for the diagnosis of diabetes mellitus in high risk individuals. , 2000, Annals of the Academy of Medicine, Singapore.
[30] Johannes B Reitsma,et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies , 2006, BMC medical research methodology.
[31] J. Chan,et al. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. , 2000, Diabetes care.
[32] N. Perkins,et al. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. , 2006, American journal of epidemiology.
[33] M. Matsumoto,et al. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. , 2007, Diabetes research and clinical practice.
[34] Diagnostic value of glycated haemoglobin (HbA1c) for the early detection of diabetes in high‐risk subjects , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[35] T. Jørgensen,et al. Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8) , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[36] David M Nathan,et al. Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus , 2002, Annals of Internal Medicine.
[37] Ben A. Dwamena,et al. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies , 2007 .
[38] J. Tijssen,et al. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population , 2011, Journal of diabetes.
[39] J. Shaw,et al. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. , 2012, Diabetes research and clinical practice.
[40] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[41] L. Papoz,et al. [Is HbA1c appropriate for the screening of diabetes in general pratice?]. , 2002, Diabetes & metabolism.
[42] S. Dharmage,et al. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[43] G. Guyatt,et al. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. , 1994, JAMA.
[44] Cas Weykamp,et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. , 2004, Clinical chemistry.
[45] Lei Zhang,et al. Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China , 2009, Diabetes Care.
[46] T. Ninomiya,et al. Cut‐off values of fasting and post‐load plasma glucose and HbA1c for predicting Type 2 diabetes in community‐dwelling Japanese subjects: the Hisayama Study , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[47] M. Matsumoto,et al. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[48] K. Park,et al. Hemoglobin A1c as a Diagnostic Tool for Diabetes Screening and New-Onset Diabetes Prediction , 2011, Diabetes Care.
[49] R. DeFronzo,et al. Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes , 2009, Diabetes Care.
[50] Y. Ni. The value of HbA1c for diagnosing type 2 diabetes in high-risk population , 2010 .
[51] Hiroshi Kambe,et al. Combined Measurement of Fasting Plasma Glucose and A1C Is Effective for the Prediction of Type 2 Diabetes , 2009, Diabetes Care.
[52] J. Mordes,et al. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. , 2011, The American journal of medicine.
[53] N. Tajima,et al. Hemoglobin A1c in predicting progression to diabetes. , 2010, Diabetes research and clinical practice.
[54] R. D'Agostino,et al. Effect of Aging on A1C Levels in Persons without Diabetes: Evidence from the Framingham Offspring Study and NHANES 2001-2004 , 2008 .
[55] D. Leong,et al. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening. , 2003, Diabetes care.